Epirubicin News and Research

RSS
Researchers identify new gene signature that predicts cancer recurrence in certain breast tumors

Researchers identify new gene signature that predicts cancer recurrence in certain breast tumors

INS cites FDA-approved Totect antidote for anthracycline extravasations

INS cites FDA-approved Totect antidote for anthracycline extravasations

CytRx plans Phase 2 clinical trial of its doxorubicin prodrug for advanced gastric cancer

CytRx plans Phase 2 clinical trial of its doxorubicin prodrug for advanced gastric cancer

Capecitabine in chemotherapy regimen reduces early breast cancer recurrence

Capecitabine in chemotherapy regimen reduces early breast cancer recurrence

NCCN Guidelines for breast cancer does not recommend prophylactic mastectomy in women

NCCN Guidelines for breast cancer does not recommend prophylactic mastectomy in women

New research sheds light on ways to improve treatment for aggressive breast cancer

New research sheds light on ways to improve treatment for aggressive breast cancer

Gene alterations associated with response to anthracycline therapy for breast cancer

Gene alterations associated with response to anthracycline therapy for breast cancer

Researchers show how anthracycline class of chemotherapeutics block blood vessel growth, slow cancer spread

Researchers show how anthracycline class of chemotherapeutics block blood vessel growth, slow cancer spread

New research moves us one step closer to personalised breast cancer treatment

New research moves us one step closer to personalised breast cancer treatment

Adding Taxotere to chemotherapy regimen improves survival in early breast cancer

Adding Taxotere to chemotherapy regimen improves survival in early breast cancer

Herceptin and chemotherapy improves response rates without major adverse effects in HER2 breast cancer

Herceptin and chemotherapy improves response rates without major adverse effects in HER2 breast cancer

Postoperative chemotherapy does not improve survival in gastric cancer patients

Postoperative chemotherapy does not improve survival in gastric cancer patients

FDA approves approved Ixempra (ixabepilone) for advanced breast cancer

FDA approves approved Ixempra (ixabepilone) for advanced breast cancer

Intra-arterial combination chemotherapy induces long-term survival for hepatocellular carcinoma

Intra-arterial combination chemotherapy induces long-term survival for hepatocellular carcinoma

PET scans accurately detect a breast tumor's response to chemotherapy

PET scans accurately detect a breast tumor's response to chemotherapy

Testing for the activity of certain genes can predict response to chemotherapy for breast cancer

Testing for the activity of certain genes can predict response to chemotherapy for breast cancer

A combination of chemotherapy drugs could double survival rates for pancreatic cancer

A combination of chemotherapy drugs could double survival rates for pancreatic cancer

Herceptin - more powerful treatment for patients with HER-2-positive breast cancer

Herceptin - more powerful treatment for patients with HER-2-positive breast cancer

Herceptin shows real promise in treatment of HER-2 positive breast disease

Herceptin shows real promise in treatment of HER-2 positive breast disease

First patient dosed with Tesmilifene in pivotal breast cancer study

First patient dosed with Tesmilifene in pivotal breast cancer study